← Back to Search

Behavioural Intervention

Internet-Based App for Breast Cancer Treatment Adherence

N/A

Recruiting

Led By Deepthi Kodali, MBBS

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age >= 18

Early-stage hormone receptor positive, HER2-negative breast cancer who have completed all recommended (neo)adjuvant chemotherapy, surgery and/or radiation therapy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

Study Summary

This trial is looking at whether an internet-based app can help improve adherence to a cancer treatment regimen.

Who is the study for?

This trial is for adults over 18 with early-stage hormone receptor-positive, HER2-negative breast cancer who've finished recommended treatments and started on aromatase inhibitors or Tamoxifen within the last six months. Participants need internet access and must speak English.Check my eligibility

What is being tested?

The study tests a web-based app designed to help patients stick to their endocrine therapy. It includes features like medication reminders, educational videos about side effect management, and direct contact with healthcare providers.See study design

What are the potential side effects?

While not directly related to the app intervention being tested, endocrine therapy can cause joint pain, hot flashes, fatigue, mood changes, and decreased bone density among other potential side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have early-stage, hormone receptor positive, HER2-negative breast cancer and have completed all recommended treatments.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility (Acceptability)

Feasibility (Compliance)

Secondary outcome measures

Adherence

Patient satisfaction

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single Arm (internet intervention, best practice)Experimental Treatment4 Interventions

Patients receive access to the app in addition to standard of care for 3 months. Through the app, patients receive weekly reminders about hormone therapy, report any side effects, access educational videos that provide tips to help mitigate some of these side effects, and allow patients to send messages to members of our breast cancer team about any questions patients may have about the side effects they may be experiencing.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,638 Previous Clinical Trials

2,560,502 Total Patients Enrolled

28 Trials studying Breast Cancer

3,028 Patients Enrolled for Breast Cancer

National Cancer Institute (NCI)NIH

13,662 Previous Clinical Trials

40,926,043 Total Patients Enrolled

940 Trials studying Breast Cancer

1,543,360 Patients Enrolled for Breast Cancer

Deepthi Kodali, MBBSPrincipal InvestigatorEmory University Hospital/Winship Cancer Institute

Media Library

Web Based App Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05488145 — N/A

Breast Cancer Research Study Groups: Single Arm (internet intervention, best practice)

Breast Cancer Clinical Trial 2023: Web Based App Intervention Highlights & Side Effects. Trial Name: NCT05488145 — N/A

Web Based App Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05488145 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an opportunity for participants to join this experiment?

"According to the details on clinicaltrials.gov, this study is not recruiting patients at present; it was originally posted and last updated in early 2023. Despite that, there are presently 4576 other medical experiments searching for volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy

Jane Meisel 2023. "A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05488145.